Save your place

Sign in to WhoBought

Please try again later.

HilleVax, Inc. (HLVX) institutional ownership

Market cap$105M SectorHealthcare
Funds holding · Q4 2025
2
reported HLVX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q4 2025
Activity unavailable N/A
0 buyers · 2 sellers

HilleVax, Inc. (HLVX) price and institutional activity

Dates

Q4 2025

$0 bought by 0 investors
$0 sold by 2 investors
Xtx Topco LtdBarclays PLC
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

HilleVax, Inc. (HLVX) institutional activity · 2

Investor Type Est. change Change Δ Own Date
Xtx Topco Ltd · Exited
Change −179K Δ Own −100.0% Date Q4 2025
Xtx Topco Ltd Exited· Q4 2025 −179K −100.0% Q4 2025
Barclays PLC · Exited
Change −42K Δ Own −100.0% Date Q4 2025
Barclays PLC Exited· Q4 2025 −42K −100.0% Q4 2025
Data through Q4 2025 · filed Mar 19, 2026
2 of 2

Famous investor activity in HilleVax, Inc. (HLVX)

HilleVax, Inc. (HLVX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Takeda Pharmaceutical Co Ltd · 10% Owner Other Form 4 events -$13M
Price $1.95 Qty -6.7M Owned 0 Trade date Sep 17, 2025 Filed date Sep 19, 2025
Takeda Pharmaceutical Co Ltd 10% Owner Other Form 4 events $1.95 -6.7M -$13M 0 Sep 17, 2025 Sep 19, 2025
Topper James N. · 10% Owner 2 operations -$17M
Price $1.95 Qty -8.6M Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Topper James N. 10% Owner 2 operations $1.95 -8.6M -$17M 0 Sep 17, 2025 Sep 17, 2025
Hershberg Robert · Director, Officer Other Form 4 events -1.1M
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Hershberg Robert Director, Officer Other Form 4 events -1.1M 0 Sep 17, 2025 Sep 17, 2025
Cocero Nanette · Director Other Form 4 events -17K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Cocero Nanette Director Other Form 4 events -17K 0 Sep 17, 2025 Sep 17, 2025
Hilleman Jeryl L. · Director Other Form 4 events -59K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Hilleman Jeryl L. Director Other Form 4 events -59K 0 Sep 17, 2025 Sep 17, 2025
Chu Shelley · Director Other Form 4 events -17K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Chu Shelley Director Other Form 4 events -17K 0 Sep 17, 2025 Sep 17, 2025
Dubin Gary · Director Other Form 4 events -17K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Dubin Gary Director Other Form 4 events -17K 0 Sep 17, 2025 Sep 17, 2025
Kohli Aditya · Director Other Form 4 events -698K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Kohli Aditya Director Other Form 4 events -698K 0 Sep 17, 2025 Sep 17, 2025
Gerberding Julie L. · Director Other Form 4 events -59K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Gerberding Julie L. Director Other Form 4 events -59K 0 Sep 17, 2025 Sep 17, 2025
Sepulveda Jaime · Director Other Form 4 events -59K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Sepulveda Jaime Director Other Form 4 events -59K 0 Sep 17, 2025 Sep 17, 2025
Maltbie Shane · Officer Other Form 4 events -84K
Owned 0 Trade date Sep 17, 2025 Filed date Sep 17, 2025
Maltbie Shane Officer Other Form 4 events -84K 0 Sep 17, 2025 Sep 17, 2025
11 of 11

HilleVax, Inc. (HLVX) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Takeda Pharmaceutical Co Ltd 6.7M
% of shares outstanding 17.1% Filing date May 9, 2022
Takeda Pharmaceutical Co Ltd 6.7M 17.1% May 9, 2022
Deep Track Capital, LP
% of shares outstanding 6.0% Filing date Feb 14, 2024
Deep Track Capital, LP 6.0% Feb 14, 2024
Lightspeed Venture Partners Select Iv, L.P. 2.3M
% of shares outstanding 4.8% Filing date Feb 14, 2024
Lightspeed Venture Partners Select Iv, L.P. 2.3M 4.8% Feb 14, 2024
Flynn James E 2.1M
% of shares outstanding 4.4% Filing date Feb 12, 2024
Flynn James E 2.1M 4.4% Feb 12, 2024
Frazier Life Sciences Public Fund, L.P. 1.9M
% of shares outstanding 3.9% Filing date May 31, 2024
Frazier Life Sciences Public Fund, L.P. 1.9M 3.9% May 31, 2024
Carlyle Group Inc. 1.8M
% of shares outstanding 3.8% Filing date Feb 12, 2024
Carlyle Group Inc. 1.8M 3.8% Feb 12, 2024
Ecor1 Capital, LLC 0
% of shares outstanding 0.0% Filing date Nov 14, 2025
Ecor1 Capital, LLC 0 0.0% Nov 14, 2025
Ra Capital Management, L.P.
% of shares outstanding 0.0% Filing date Feb 14, 2024
Ra Capital Management, L.P. 0.0% Feb 14, 2024
8 of 8

HilleVax, Inc. (HLVX) ownership FAQ

Who owns HLVX?

2 reporting institutions disclosed HLVX position changes in the Q4 2025 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q4 2025.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.